Eng Aik Meng
Non-Executive and
Non-Independent Director
Mr Eng joined the SATS Board on 15 April 2023 as a Non-Executive and Independent Director and subsequently, was re-designated as a Non-Executive and Non-Independent Director on 1 September 2024 following his executive appointments in Temasek International Pte. Ltd. (“Temasek International”). He is currently a member of the Remuneration and Human Resource Committee and the Nominating Committee. He was last re-elected as a Director on 21 July 2023.
Mr Eng has over 30 years of global business and operating experience in the healthcare and maritime industries, including a proven track record in private equity investments. His present principal commitments include his roles as the joint head of the Portfolio Development Group and head of the Operating Group at Temasek International. He also serves as a non-executive and non-independent director at Seatrium Limited, a company listed on the SGX-ST.
Mr Eng has held various prominent roles in the past, including co-founder of TE Asia Healthcare Partners, group chief executive officer of TE Healthcare Advisory Pte Ltd., and group chief operating officer of Fortis Healthcare International. He also worked as a senior advisor for TPG Capital, where he was involved in directorships and leadership roles across portfolio companies. Before joining the healthcare industry, Mr Eng spent 18 years with Neptune Orient Lines in various leadership roles.
Mr Eng holds a Bachelor of Accountancy with Honours from Nanyang Technological University and an MBA from Harvard University.